Aegon NV (NYSE:AEG) Making a Turnaround
By Jim Van Meerten This morning I added Aegon NV (NYSE:AEG) to the Barchart Van Meerten New High portfolio as a turnaround opportunity. Aegon N.V. is an international insurance group which writes life...
View ArticleIntroduction to the Leveraged Buyout
By Growth Stock Investor Introduction: A Leveraged Buyout (LBO) is, in simplicity, when Company A (the Acquirer or Financial Sponsor) buys Company B (the Target) using mostly debt to finance the cost...
View ArticleDeconstructing Warren Buffett on Bonds, Gold and Housing
By Charles Sizemore The Oracle of Omaha has had a lot to say in recent years, and by his own admission not a lot of it is new. This is not to say that Warren Buffett is incapable of change, of course;...
View ArticlePeter Schiff: Legal Gimmickry Rescues Obama
By Peter Schiff Despite the celebrations among Democrats, yesterday a majority of Supreme Court justices ruled that the Constitution does not allow the government to force Americans to buy health...
View ArticlePeter Schiff: Supreme Errors
By Peter Schiff In the wake of my last commentary on the horrendous Supreme Court decision upholding Obama’s health care plan, several people have pointed out that I erred in saying that the income tax...
View ArticleDendreon Corporation (NASDAQ:DNDN): Beaten Down, But Still Not Out
By VFC’s Stock House Investors may be wondering if Dendreon Corporation (NASDAQ:DNDN) can ever catch a break. A few years ago positive Phase III results for the company’s immunotherapeutic prostate...
View ArticleRobert Reich: Governor Mitt Romney’s Question Mark Economy
By Robert Reich As we close in on Election Day, the questions about what Mitt Romney would do if elected grow even larger. Rarely before in American history has a candidate for president campaigned on...
View ArticleRBS Morgans Senior Analyst Scott Power Finds the Upside in Biotech Down...
By George S. Mack If you’re looking for fresh international names in biotech and medtech, but need the comforts of end markets on U.S. soil, the best ideas of RBS Morgans Ltd. Senior Analyst Scott...
View ArticleThe Ongoing War: After the Battle Over the Fiscal Cliff, the Battle Over the...
By Robert Reich “It’s not all I would have liked,” says Republican Senator Lindsey Graham of South Carolina, speaking of the deal on the fiscal cliff, “so on to the debt ceiling.” For Republicans, the...
View ArticleRetrophin (RTRX) Is Worth A Look
By Spencer Osborne Retrophin (PINK:RTRX), a pharmaceutical start-up, is building a business in an otherwise competitive sector by focusing on a sub-category called orphan drugs. An orphan drug is one...
View ArticleHow to Choose the Best European Dividend ETF (DVY, VIG, FDD, SAN, DOO, PID,...
By Charles Sizemore Last year, I compared U.S. dividend ETFs and gave readers a simple choice. If you want current income, a high-yielding option like the iShares Dow Jones Select Dividend ETF...
View ArticleArena (ARNA) and Vivus (VVUS) Battle it Out to Slim the World
By Glen S. Woods Roughly 300,000 people die each year due to obesity related complications. Two-thirds of the population of the U.S. is overweight, and one-third is considered obese. Obesity is no...
View ArticleWeekly Stock Watch: SNWV, SSH, FPMI, AA, WMT, PIR, BBBY, HTWR, THOR
By VFC’s Stock House As the broad market rally looks to have sputtered, and with the upcoming earnings season not expected to blow away estimates by any means, investors will be looking to bank profits...
View ArticleSpecialty Pharmacies Offer Solutions — Also For Investors: PMC, BIOS, APHY
By Dutch Trader In 2012, Americans filled more than 4 billion prescriptions at 62,000 retail, mail, and specialty pharmacies. The largest U.S. pharmacies ranked by total prescription you will find in...
View ArticleChaz Bono Gives Weight Loss Drugs Celebrity Appeal — Arena Pharmaceuticals...
By Spencer Osborne Chaz Bono is famous for several reasons. First and foremost Chaz was born the child of Sonny and Cher. Secondly Chaz was famous for being transgender and undergoing a sex change...
View Article
